• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国大规模免疫接种期间预期的基础疾病事件数。

The expected number of background disease events during mass immunization in China.

机构信息

School of Public Health, Capital Medical University, Beijing, China ; Municipal Key Laboratory of Clinical Epidemiology, Beijing, China ; School of Medical Sciences, Edith Cowan University, Perth, Australia.

出版信息

PLoS One. 2013 Aug 20;8(8):e71818. doi: 10.1371/journal.pone.0071818. eCollection 2013.

DOI:10.1371/journal.pone.0071818
PMID:23977153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3748117/
Abstract

It is critical to distinguish events that are temporarily associated with, but not caused by, vaccination from those caused by vaccination during mass immunization. We performed a literature search in China National Knowledge Infrastructure and Pubmed databases. The number of coincident events was calculated based on its incidence rate and periods after receipt of a dose of hypothesized vaccine. We included background incidences of Guillain-Barré syndrome, anaphylaxis, seizure, sudden adult death syndrome, sudden cardiac death, spontaneous abortion, and preterm labour or delivery. In a cohort of 10 million individuals, 7.71 cases of Guillain-Barré syndrome would be expected to occur within six weeks of vaccination as coincident background cases. Even for rare events, a large number of events can be expected in a short period because of the large population targeted for immunization. These findings may encourage health authorities to screen the safety of vaccines against unpredictable pathogens.

摘要

在大规模免疫接种期间,区分与疫苗接种暂时相关但并非由疫苗接种引起的事件与由疫苗接种引起的事件至关重要。我们在中国国家知识基础设施和 PubMed 数据库中进行了文献检索。根据假设疫苗接种后发病率和时间,计算了偶合事件的数量。我们包括 Guillain-Barré 综合征、过敏反应、癫痫发作、青少年猝死综合征、心脏性猝死、自然流产和早产或分娩的背景发病率。在 1000 万人的队列中,预计在接种疫苗后 6 周内会有 7.71 例 Guillain-Barré 综合征病例作为偶合背景病例发生。即使是罕见事件,由于针对大量人群进行免疫接种,短期内也会出现大量事件。这些发现可能会鼓励卫生当局对针对不可预测病原体的疫苗进行安全性筛选。

相似文献

1
The expected number of background disease events during mass immunization in China.中国大规模免疫接种期间预期的基础疾病事件数。
PLoS One. 2013 Aug 20;8(8):e71818. doi: 10.1371/journal.pone.0071818. eCollection 2013.
2
Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.美国甲型 H1N1 2009 流感单价灭活疫苗与格林-巴利综合征的关联性:一项荟萃分析。
Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13.
3
Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.在拉丁美洲和加勒比地区甲型H1N1流感大流行疫苗接种活动期间,据认为可归因于疫苗接种或免疫的事件。
Vaccine. 2015 Jan 1;33(1):187-92. doi: 10.1016/j.vaccine.2014.10.070. Epub 2014 Nov 6.
4
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.在大规模式人群接种甲型 H1N1 流感疫苗时评估疫苗安全性时疾病背景发生率的重要性。
Lancet. 2009 Dec 19;374(9707):2115-2122. doi: 10.1016/S0140-6736(09)61877-8. Epub 2009 Oct 31.
5
Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.格林-巴利综合征与含佐剂的大流行性流感 A(H1N1)2009 疫苗:欧洲多国自身对照病例系列研究。
PLoS One. 2014 Jan 3;9(1):e82222. doi: 10.1371/journal.pone.0082222. eCollection 2014.
6
Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.韩国甲型大流行性流感疫苗接种与吉兰-巴雷综合征发病率
Vaccine. 2015 Apr 8;33(15):1815-23. doi: 10.1016/j.vaccine.2015.02.035. Epub 2015 Feb 26.
7
Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.魁北克地区 H1N1 流感疫苗接种后发生格林-巴利综合征的风险。
JAMA. 2012 Jul 11;308(2):175-81. doi: 10.1001/jama.2012.7342.
8
Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.格林-巴利综合征与含佐剂大流行性流感 A(H1N1)2009 疫苗:欧洲多国病例对照研究。
BMJ. 2011 Jul 12;343:d3908. doi: 10.1136/bmj.d3908.
9
Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.北京地区 2009 年 H1N1 流感疫苗的安全性和有效性
N Engl J Med. 2010 Dec 16;363(25):2416-23. doi: 10.1056/NEJMoa1006736.
10
Population-Based Incidence of Guillain-Barré Syndrome During Mass Immunization With Viral Vaccines: A Pooled Analysis.基于人群的病毒疫苗大规模免疫后格林-巴利综合征的发病率: pooled 分析。
Front Immunol. 2022 Feb 3;13:782198. doi: 10.3389/fimmu.2022.782198. eCollection 2022.

引用本文的文献

1
Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance.背景 2015 年至 2020 年,加拿大安大略省与 COVID-19 疫苗相关的特殊关注不良事件的基础发病率,用于为 COVID-19 疫苗安全性监测提供信息。
Vaccine. 2022 May 26;40(24):3305-3312. doi: 10.1016/j.vaccine.2022.04.065. Epub 2022 Apr 27.
2
Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study.背景:加拿大安大略省 COVID-19 疫苗安全性评估中,血栓栓塞和凝血障碍住院和急诊就诊的背景发病率:一项基于人群的回顾性观察研究。
BMJ Open. 2021 Dec 17;11(12):e052019. doi: 10.1136/bmjopen-2021-052019.
3
The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.在日本广泛开展全国性疫苗接种计划之前,特定临床病症的背景发病情况。
PLoS One. 2021 Aug 26;16(8):e0256379. doi: 10.1371/journal.pone.0256379. eCollection 2021.
4
Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects.约旦新冠疫苗接种后的副作用及认知:一项采用机器学习预测副作用严重程度的随机横断面研究
Vaccines (Basel). 2021 May 26;9(6):556. doi: 10.3390/vaccines9060556.
5
Ten years of vaccinovigilance in Italy: an overview of the pharmacovigilance data from 2008 to 2017.意大利十年疫苗监测:2008 年至 2017 年药物监测数据概述。
Sci Rep. 2020 Aug 24;10(1):14122. doi: 10.1038/s41598-020-70996-x.
6
Demonstration of background rates of three conditions of interest for vaccine safety surveillance.疫苗安全监测中三种关注情况的背景发生率的展示。
PLoS One. 2019 Jan 15;14(1):e0210833. doi: 10.1371/journal.pone.0210833. eCollection 2019.
7
Multiple genetic variants associated with posttransplantation diabetes mellitus in Chinese Han populations.中国汉族人群中与移植后糖尿病相关的多个基因变异体。
J Clin Lab Anal. 2018 Mar;32(3). doi: 10.1002/jcla.22308. Epub 2017 Aug 23.

本文引用的文献

1
Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign.为应对大流行流感 H1N1/09 免疫接种运动期间的安全问题,在安大略省估算吉兰-巴雷综合征的背景发病率。
BMC Public Health. 2011 May 17;11:329. doi: 10.1186/1471-2458-11-329.
2
Awareness of the background rate of sudden cardiac death during mass immunization with pandemic H1N1 influenza vaccines increases the intended vaccination rate.
Prev Med. 2010 Nov;51(5):445-6. doi: 10.1016/j.ypmed.2010.08.019. Epub 2010 Sep 9.
3
[Preterm birth and preterm infants in Beijing regional district].[北京地区的早产与早产儿]
Zhonghua Fu Chan Ke Za Zhi. 2010 Feb;45(2):99-103.
4
Causes of deaths in children younger than 5 years in China in 2008.2008 年中国 5 岁以下儿童死亡原因。
Lancet. 2010 Mar 27;375(9720):1083-9. doi: 10.1016/S0140-6736(10)60060-8.
5
Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.2009 年甲型 H1N1 流感大流行疫苗单独或与 2009-10 年流感季节季节性流感疫苗同时接种的安全性和免疫原性:一项多中心、随机对照试验。
Lancet. 2010 Jan 2;375(9708):49-55. doi: 10.1016/S0140-6736(09)62039-0. Epub 2009 Dec 15.
6
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.美国针对 2009 年甲型 H1N1 流感的单次疫苗接种后的免疫反应:两项随机对照 2 期试验的初步报告。
Lancet. 2010 Jan 2;375(9708):41-8. doi: 10.1016/S0140-6736(09)62026-2. Epub 2009 Dec 15.
7
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.中国 2009 年甲型 H1N1 流感疫苗的安全性和免疫原性:一项多中心、双盲、随机、安慰剂对照试验。
Lancet. 2010 Jan 2;375(9708):56-66. doi: 10.1016/S0140-6736(09)62003-1. Epub 2009 Dec 15.
8
Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008.2007 年至 2008 年中国四川省大规模疫苗接种运动中报告的麻疹疫苗不良反应事件。
Vaccine. 2011 Apr 18;29(18):3507-10. doi: 10.1016/j.vaccine.2009.10.106. Epub 2009 Nov 10.
9
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.在大规模式人群接种甲型 H1N1 流感疫苗时评估疫苗安全性时疾病背景发生率的重要性。
Lancet. 2009 Dec 19;374(9707):2115-2122. doi: 10.1016/S0140-6736(09)61877-8. Epub 2009 Oct 31.
10
Incidence of sudden cardiac death in China: analysis of 4 regional populations.中国心脏性猝死的发病率:4个地区人群的分析
J Am Coll Cardiol. 2009 Sep 15;54(12):1110-8. doi: 10.1016/j.jacc.2009.06.016.